Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors

被引:106
作者
Cherenfant, Jovenel [1 ]
Stocker, Susan J. [1 ]
Gage, Mistry K. [1 ]
Du, Hongyan [1 ]
Thurow, Tiffany A. [1 ]
Odeleye, Melanie [4 ]
Schimpke, Scott W. [5 ]
Kaul, Karen L. [1 ]
Hall, Curtis R. [1 ]
Lamzabi, Ihab [5 ]
Gattuso, Paolo [5 ]
Winchester, David J. [1 ]
Marsh, Robert W. [1 ]
Roggin, Kevin K. [4 ]
Bentrem, David J. [2 ,3 ]
Baker, Marshall S. [1 ]
Prinz, Richard A. [1 ]
Talamonti, Mark S. [1 ]
机构
[1] NorthShore Univ HealthSyst, Evanston, IL 60201 USA
[2] Northwestern Feinberg Sch Med, Chicago, IL USA
[3] Jesse Brown Med Ctr, Chicago, IL USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
PROGNOSTIC-FACTORS; SURVIVAL; PANCREATICODUODENECTOMY; NEOPLASMS; RESECTION;
D O I
10.1016/j.surg.2013.07.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. The biologic potential of nonfunctioning pancreatic neuroendocrine tumors (PNETs) is highly variable and difficult to predict before resection. This study was conducted to identify clinical and pathologic factors associated with malignant behavior and death in patients diagnosed with PNETs. Methods. We used International Classification of Diseases 9th edition codes to identify patients who underwent pancreatectomy for PNETs from 1998 to 2011 in the databases of 4 institutions. Functioning PNETs were excluded. Multivariate regression Cox proportional models were constructed to identify clinical and pathologic factors associated with distant metastasis and survival. Results. The study included 128 patients-57 females and 71 males. The age (mean +/- standard deviation) was 55 +/- 14 years. The body mass index was 28 +/- 5 kg/m(2). Eighty-nine (70%) patients presented with symptoms, and 39 (30%) had tumors discovered incidentally. The tumor size was 3.3 +/- 2 cm with 56 (44%) of the tumors measuring <= 2 cm. Seventy-three (57%) patients had grade 1 histology tumors, 37 (29%) had grade 2, and 18 (14%) had grade 3. Peripancreatic lymph node involvement was present in 31 patients (24%), absent in 75 (59%), and unknown in 22 (17%). Distant metastasis occurred in 18 patients (14%). There were 12 deaths, including 1 perioperative, 8 disease related, and 3 of unknown cause. With a median follow-up of 33 months, the overall 5-year survival was 75%. Multivariate Cox regression analysis identified age >55 (hazard ratio [HR], 5.89; 95% confidence interval [CI], 1.64-20.58), grade 3 histology (IIR, 6.08; 95% CI, 1.32-30.2), and distant metastasis (HR 8.79; 95% CI, 2.67-28.9) as risk factors associated with death (P < .05). Gender, race, body mass index, clinical symptoms, lymphovascular and perineural invasion, and tumor size were not related to metastasis or survival (P > .05). Three patients with tumors <= 2 cm developed distant metastasis resulting in 2 disease-related deaths. Conclusion. Age >55 years, grade 3 histology, and distant metastasis predict a greater risk of death from nonfunctioning PNETs. Resection or short-term, surveillance should be considered regardless of tumor size.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 21 条
  • [1] [Anonymous], J GASTROINTEST SURG
  • [2] Pancreatic endocrine tumors
    Asa, Sylvia L.
    [J]. MODERN PATHOLOGY, 2011, 24 : S66 - S77
  • [3] Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors - Analysis of 3851 patients
    Bilimoria, Karl Y.
    Talamonti, Mark S.
    Tomlinson, James S.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Bentrem, David J.
    [J]. ANNALS OF SURGERY, 2008, 247 (03) : 490 - 500
  • [4] Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients
    Bilimoria, Karl Y.
    Tomlinson, James S.
    Merkow, Ryan P.
    Stewart, Andrew K.
    Ko, Clifford Y.
    Talamonti, Mark S.
    Bentrem, David J.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (11) : 1460 - 1467
  • [5] Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Chatterjee, Deyali
    Katz, Matthew H.
    Rashid, Asif
    Wang, Hua
    Iuga, Alina C.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Lee, Jeffrey E.
    Pisters, Peter W.
    Crane, Christopher H.
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 409 - 417
  • [6] Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion
    Chen, John W. C.
    Bhandari, Mayank
    Astill, David S.
    Wilson, Thomas G.
    Kow, Lilian
    Brooke-Smith, Mark
    Toouli, James
    Padbury, Robert T. A.
    [J]. HPB, 2010, 12 (02) : 101 - 108
  • [7] Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
    Ekeblad, Sara
    Skogseid, Britt
    Dunder, Kristina
    Oberg, Kjell
    Eriksson, Barbro
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (23) : 7798 - 7803
  • [8] An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors
    Fendrich, Volker
    Langer, Peter
    Celik, Ilhan
    Bartsch, Detlef K.
    Zielke, Andreas
    Ramaswamy, Anette
    Rothmund, Matthias
    [J]. ANNALS OF SURGERY, 2006, 244 (06) : 845 - 853
  • [9] Surgical Treatment of Pancreatic Neuroendocrine Tumors: Report of 112 Cases
    Gao, Chuntao
    Fu, Xiuqing
    Pan, Yi
    Li, Qiang
    [J]. DIGESTIVE SURGERY, 2010, 27 (03) : 197 - 204
  • [10] Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors Short-term and Long-term Patient Outcomes
    Haynes, Alex B.
    Deshpande, Vikram
    Ingkakul, Thun
    Vagefi, Parsia A.
    Szymonifka, Jackie
    Thayer, Sarah P.
    Ferrone, Cristina R.
    Wargo, Jennifer A.
    Warshaw, Andrew L.
    Fernandez-del Castillo, Carlos
    [J]. ARCHIVES OF SURGERY, 2011, 146 (05) : 534 - 538